- Home
- BW vs ACHV Comparison
BW vs ACHV Comparison
Compare BW & ACHV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BW
- ACHV
- Stock Information
- Founded
- BW 1867
- ACHV N/A
- Country
- BW United States
- ACHV Canada
- Employees
- BW N/A
- ACHV N/A
- Industry
- BW Building Products
- ACHV Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- BW Industrials
- ACHV Health Care
- Exchange
- BW Nasdaq
- ACHV Nasdaq
- Market Cap
- BW 182.0M
- ACHV 149.6M
- IPO Year
- BW N/A
- ACHV N/A
- Fundamental
- Price
- BW $1.70
- ACHV $4.10
- Analyst Decision
- BW Strong Buy
- ACHV Strong Buy
- Analyst Count
- BW 3
- ACHV 5
- Target Price
- BW $4.50
- ACHV $14.80
- AVG Volume (30 Days)
- BW 876.3K
- ACHV 113.3K
- Earning Date
- BW 11-12-2024
- ACHV 11-07-2024
- Dividend Yield
- BW N/A
- ACHV N/A
- EPS Growth
- BW N/A
- ACHV N/A
- EPS
- BW N/A
- ACHV N/A
- Revenue
- BW $878,224,000.00
- ACHV N/A
- Revenue This Year
- BW N/A
- ACHV N/A
- Revenue Next Year
- BW N/A
- ACHV N/A
- P/E Ratio
- BW N/A
- ACHV N/A
- Revenue Growth
- BW N/A
- ACHV N/A
- 52 Week Low
- BW $0.75
- ACHV $3.20
- 52 Week High
- BW $2.99
- ACHV $5.59
- Technical
- Relative Strength Index (RSI)
- BW 40.51
- ACHV 38.91
- Support Level
- BW $1.73
- ACHV $4.02
- Resistance Level
- BW $1.91
- ACHV $4.66
- Average True Range (ATR)
- BW 0.12
- ACHV 0.17
- MACD
- BW -0.01
- ACHV -0.02
- Stochastic Oscillator
- BW 10.11
- ACHV 23.44
About BW Babcock & Wilcox Enterprises Inc.
Babcock & Wilcox Enterprises Inc is a power generation equipment supplier and servicing company that operates in three segments: B&W Renewable, B&W Environmental, and B&W Thermal. B&W Thermal, focuses on steam generation products and solutions for plants in the power generation, oil, and gas, and industrial sectors, generates the majority of the company's revenue. B&W Renewable focuses on sustainable power and heat generation while B&W Environmental focuses on emissions control. The company's customer base spans the industrial, electrical utility, and municipal industries located predominantly in the United States, Canada, Denmark, the United Kingdom, and other regions. Business in the U.S. contributes the vast majority of its revenue.
About ACHV Achieve Life Sciences Inc.
Achieve Life Sciences Inc is a specialty pharmaceutical company committed to advancing cytisinicline as a widely available treatment option to help people battling nicotine addiction. It is an established smoking cessation treatment that has been approved and marketed in Central and Eastern Europe. Achieve's focus is to address the smoking health epidemic through the development and commercialization of cytisinicline. It has one operating segment, dedicated to the development and commercialization of cytisinicline for niceon.